Green W R, Nowinski R C, Henney C S
J Exp Med. 1979 Jul 1;150(1):51-66. doi: 10.1084/jem.150.1.51.
Efforts were made to generate C57BL/6 cytotoxic effector cells to a syngeneic leukemia (E{male}G2) bearing AKR/Gross virus antigens. As we were unable to induce significant cytotoxic activity by immunization with up to 10(8) irradiated E{male}G2 cells, even when cells from such primed animals were subsequently restimulated with E{male}G2 cells in vitro, C57BL/6 mice were immunized with an aliogeneic, virus-producing AKR leukemic cell line (AKR SL3). Peritoneal exudate cells and, to a lesser degree, spleen cells from these mice showed significant lytic activity toward the immunizing allogeneic tumor but not toward E{male}G2. When spleen cells were harvested from animals {approximately equal to}10 d after injection of AKR SL3 and rechallenged in vitro with either E{male}G2 or AKR.H-2(b) SL1, another tumor that displays AKR/Gross virus antigens, then a vigorous cytotoxic response against E{male}G2 and AKR. H-2(b) SL1 was obtained. Effector cells generated by AKR SL3 priming followed by in vitro stimulation with E{male}G2 or AKR.H-2(b) SL1 lysed only cells of H-2(b) haplotype which were strongly positive for the display of serologically detectable AKR/Gross virus antigens. Thus, AKR SL3 cells were not lysed nor were EL4 cells (H-2(b); but only weakly positive for gp70). Cells not bearing the MuLV antigens tested for, such as P815 mastocytoma cells and spleen cell "blasts" from C57BL/6 and CBA (H-2(k)) mice, were also insusceptible to attack. The cytotoxic effector cells induced bore Thy 1.2 alloantigen and were of the Lyt 1+2+ phenotype. Collectively, these findings are consistent with the conclusion that the cytotoxic T cells raised against E{male}G2 are directed against AKR/Gross virus-associated antigens and are H-2 restricted. It will be of interest to determine the relevance of such effector cells to the known resistance of the C57BL/6 mouse to AKR/Gross virus-induced leukemia.
人们致力于产生针对携带AKR/格罗斯病毒抗原的同基因白血病(E{雄性}G2)的C57BL/6细胞毒性效应细胞。由于我们用多达10(8)个经辐照的E{雄性}G2细胞免疫未能诱导出显著的细胞毒性活性,即使随后用E{雄性}G2细胞在体外对来自此类致敏动物的细胞进行再刺激,于是用一种产生病毒的异基因AKR白血病细胞系(AKR SL3)对C57BL/6小鼠进行免疫。这些小鼠的腹腔渗出细胞以及程度稍轻的脾细胞对免疫所用的异基因肿瘤显示出显著的裂解活性,但对E{雄性}G2无此活性。当在注射AKR SL3后约10天从小鼠采集脾细胞,并在体外分别用E{雄性}G2或AKR.H-2(b) SL1(另一种显示AKR/格罗斯病毒抗原的肿瘤)再次刺激时,获得了针对E{雄性}G2和AKR.H-2(b) SL1的强烈细胞毒性反应。由AKR SL3致敏随后用E{雄性}G2或AKR.H-2(b) SL1在体外刺激产生的效应细胞仅裂解H-2(b)单倍型的细胞,这些细胞对于血清学可检测到的AKR/格罗斯病毒抗原的展示呈强阳性。因此,AKR SL3细胞未被裂解,EL4细胞(H-2(b);但gp70仅呈弱阳性)也未被裂解。所检测的不携带MuLV抗原的细胞,如P815肥大细胞瘤细胞以及来自C57BL/6和CBA(H-2(k))小鼠的脾细胞“母细胞”,也不易受到攻击。诱导产生的细胞毒性效应细胞带有Thy 1.2同种异体抗原,并且具有Lyt 1+2+表型。总体而言,这些发现与以下结论一致,即针对E{雄性}G2产生的细胞毒性T细胞针对的是与AKR/格罗斯病毒相关的抗原,并且受H-2限制。确定此类效应细胞与C57BL/6小鼠对AKR/格罗斯病毒诱导的白血病的已知抗性之间的相关性将是很有意义的。